Literature DB >> 9893573

Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption.

A Sabokbar1, Y Fujikawa, D W Murray, N A Athanasou.   

Abstract

OBJECTIVE: Wear particle induced bone resorption is thought to be one of the mechanisms that contribute to implant loosening. It has previously been shown that macrophages, in response to polymethylmethacrylate (PMMA) particles, differentiate into bone resorbing osteoclasts, and that this process is inhibited by a bisphosphonate, etidronate (EHDP). The aim of this study was to determine whether incorporating EHDP in bone cement could reduce PMMA associated bone resorption.
METHODS: Two concentrations of EHDP were mixed with PMMA monomer before polymerisation. Particles of PMMA (1-10 microns) were generated then added to mouse monocytes cocultured with UMR106 rat osteoblast-like cells and the extent of osteoclast differentiation was determined by assessing the extent of tartrate resistant acid phosphatase (TRAP) staining and measuring the amount of lacunar bone resorption.
RESULTS: The addition of PMMA to monocyte-UMR106 cocultures resulted in a marked increase in the number of TRAP positive osteoclast-like cells and a significant increase in the number of lacunar resorption pits compared with control cultures to which no particles had been added. After the addition of particles of PMMA + 20 mg EHDP, significantly fewer lacunar pits (p = 0.00006) and fewer TRAP positive cells were noted compared with cocultures containing PMMA particles alone.
CONCLUSIONS: These results indicate that by mixing a bisphosphonate with bone cement, it is possible to inhibit PMMA particle induced bone resorption. This bisphosphonate inhibition of PMMA biomaterial wear particle containing macrophage-osteoclast differentiation and bone resorption may provide a possible therapeutic strategy to prevent or to control the osteolysis of aseptic loosening.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893573      PMCID: PMC1752488          DOI: 10.1136/ard.57.10.614

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Macrophages stimulate bone resorption when they phagocytose particles.

Authors:  D W Murray; N Rushton
Journal:  J Bone Joint Surg Br       Date:  1990-11

2.  Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.

Authors:  A Carano; S L Teitelbaum; J D Konsek; P H Schlesinger; H C Blair
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.

Authors:  M Sato; W Grasser
Journal:  J Bone Miner Res       Date:  1990-01       Impact factor: 6.741

4.  Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

Authors:  N Udagawa; N Takahashi; T Akatsu; H Tanaka; T Sasaki; T Nishihara; T Koga; T J Martin; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 5.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 6.  Pathologic studies of total joint replacement.

Authors:  P G Bullough; E F DiCarlo; K K Hansraj; M C Neves
Journal:  Orthop Clin North Am       Date:  1988-07       Impact factor: 2.472

7.  Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage.

Authors:  M G Cecchini; H Fleisch
Journal:  J Bone Miner Res       Date:  1990-10       Impact factor: 6.741

8.  Biomechanical and histologic investigation of cemented total hip arthroplasties. A study of autopsy-retrieved femurs after in vivo cycling.

Authors:  W J Maloney; M Jasty; D W Burke; D O O'Connor; E B Zalenski; C Bragdon; W H Harris
Journal:  Clin Orthop Relat Res       Date:  1989-12       Impact factor: 4.176

9.  Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.

Authors:  A M Flanagan; T J Chambers
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

10.  Polymethylmethacrylate-induced inflammatory macrophages resorb bone.

Authors:  J Quinn; C Joyner; J T Triffitt; N A Athanasou
Journal:  J Bone Joint Surg Br       Date:  1992-09
View more
  9 in total

Review 1.  [The use of bisphosphonates in arthroplasty].

Authors:  C Eberhardt; B Habermann; A A Kurth
Journal:  Orthopade       Date:  2007-02       Impact factor: 1.087

2.  [Supportive drugs for improved implant healing].

Authors:  R Skripitz; A Kurth; A Roth
Journal:  Orthopade       Date:  2015-09       Impact factor: 1.087

3.  Fibroblasts from the inner granulation tissue of the pseudocapsule in hips at revision arthroplasty induce osteoclast differentiation, as do stromal cells.

Authors:  H Sakai; S Jingushi; T Shuto; K Urabe; T Ikenoue; K Okazaki; T Kukita; A Kukita; Y Iwamoto
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

4.  [Biocompatibility of polymer-bioglass cement Cortoss®: in vitro test with the MG63 cell model].

Authors:  C Fölsch; R Pinkernell; R Stiletto
Journal:  Orthopade       Date:  2013-03       Impact factor: 1.087

5.  Apoptosis in interface membranes of aseptically loose total hip arthroplasty.

Authors:  O L Huk; D J Zukor; W Ralston; A Lisbona; A Petit
Journal:  J Mater Sci Mater Med       Date:  2001-07       Impact factor: 3.896

Review 6.  Local strategies to prevent and treat osteoporosis.

Authors:  F Brennan Torstrick; Robert E Guldberg
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

Review 7.  Clodronate: new directions of use.

Authors:  Bruno Frediani; Ilaria Bertoldi
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

8.  Mesoporous bioactive glass/ɛ-polycaprolactone scaffolds promote bone regeneration in osteoporotic sheep.

Authors:  N Gómez-Cerezo; L Casarrubios; M Saiz-Pardo; L Ortega; D de Pablo; I Díaz-Güemes; B Fernández-Tomé; S Enciso; F M Sánchez-Margallo; M T Portolés; D Arcos; M Vallet-Regí
Journal:  Acta Biomater       Date:  2019-04-06       Impact factor: 8.947

9.  In Vivo Release of Vancomycin from Calcium Phosphate Cement.

Authors:  Kentaro Uchida; Ken Sugo; Takehiko Nakajima; Mitsufumi Nakawaki; Shotaro Takano; Naoshige Nagura; Masashi Takaso; Ken Urabe
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.